Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 15

Original Research

Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry

         
Total article views   HTML views PDF downloads Totals
1,976 Dovepress* 1,841+ 543 2,384
PubMed Central* 135 53 188
Totals 1,976 596 2,572
*Since 3 December 2020

View citations on PubMed Central and Google Scholar